as 10-04-2024 4:00pm EST
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | MARLBOROUGH |
Market Cap: | 145.5M | IPO Year: | 2021 |
Target Price: | $6.08 | AVG Volume (30 days): | 144.6K |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.22 | EPS Growth: | N/A |
52 Week Low/High: | $1.88 - $6.31 | Next Earning Date: | 11-06-2024 |
Revenue: | $93,216,000 | Revenue Growth: | 9.66% |
Revenue Growth (this year): | 3.46% | Revenue Growth (next year): | 20.67% |
AKYA Breaking Stock News: Dive into AKYA Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
GlobeNewswire
a day ago
Simply Wall St.
2 months ago
MT Newswires
2 months ago
MT Newswires
2 months ago
MT Newswires
2 months ago
Zacks
2 months ago
Associated Press Finance
2 months ago
The information presented on this page, "AKYA Akoya BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.